These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
99 related articles for article (PubMed ID: 9284415)
1. [Genetically engineered mice for study of human hypertension]. Sugiyama F; Taniguchi K; Fukamizu A; Yagami K Nihon Rinsho; 1997 Aug; 55(8):2005-10. PubMed ID: 9284415 [TBL] [Abstract][Full Text] [Related]
2. Development of genetically engineered mice with hypertension and hypotension. Sugiyama F Exp Anim; 1997 Jul; 46(3):171-82. PubMed ID: 9250477 [TBL] [Abstract][Full Text] [Related]
3. Symposium on the etiology of hypertension--summarizing studies in 20th century. 2. Genetic engineering in hypertension research. Kurihara H Intern Med; 2001 Feb; 40(2):147-51. PubMed ID: 11300150 [No Abstract] [Full Text] [Related]
4. [Gene mutation and polymorphism as risk factors in the development of hypertensive organ damage]. Okura T Nihon Rinsho; 2004 Mar; 62 Suppl 3():92-7. PubMed ID: 15171348 [No Abstract] [Full Text] [Related]
5. The future of hypertension therapy: sense, antisense, or nonsense? Pachori AS; Huentelman MJ; Francis SC; Gelband CH; Katovich MJ; Raizada MK Hypertension; 2001 Feb; 37(2 Pt 2):357-64. PubMed ID: 11230300 [TBL] [Abstract][Full Text] [Related]
6. Genetics of primary hypertension. Ganten D; Schmidt S; Paul M J Cardiovasc Pharmacol; 1994; 24 Suppl 3():S45-50. PubMed ID: 7700065 [TBL] [Abstract][Full Text] [Related]
12. [The genetics of intermediate phenotypes in hypertension]. Koshechkina EV Ter Arkh; 1995; 67(4):59-61. PubMed ID: 7784981 [No Abstract] [Full Text] [Related]
13. [Contribution of rennin-angiotensin-aldosterone system genes and NO synthase gene to the development of arterial hypertension]. Savinetskaia GA; Golubeva AA; Pogoda TV; Generozov EV Klin Med (Mosk); 2008; 86(8):12-7. PubMed ID: 18819340 [TBL] [Abstract][Full Text] [Related]
15. [A comparative study of cardiac function in transgenic hypertensive rats, in spontaneously hypertensive rats and in normotensive rats]. Bohlender J; Hildenbrand U; Schlegel WP; Hempel P; Nissen E; Krause EG; Bartel S Arch Mal Coeur Vaiss; 2000 Aug; 93(8):993-6. PubMed ID: 10989744 [TBL] [Abstract][Full Text] [Related]
16. Long-term blockade of the angiotensin II receptor in renin transgenic rats, salt-loaded Dahl rats, and stroke-prone spontaneously hypertensive rats. Stasch JP; Knorr A; Hirth-Dietrich C; Krämer T; Hübsch W; Dressel J; Fey P; Beuck M; Sander E; Frobel K; Kazda S Arzneimittelforschung; 1997 Sep; 47(9):1016-23. PubMed ID: 9342414 [TBL] [Abstract][Full Text] [Related]
17. Autonomic control in rats with overactivity of tissue renin-angiotensin or kallikrein-kinin system. Ribeiro JM; Santos RA; Pesquero JB; Bader M; Krieger EM Regul Pept; 2005 Jul; 129(1-3):155-9. PubMed ID: 15927711 [TBL] [Abstract][Full Text] [Related]
18. The renin-angiotensin system in transgenic rats: characteristics and functional studies. Wagner J; Ganten D Semin Nephrol; 1993 Nov; 13(6):586-92. PubMed ID: 8278693 [No Abstract] [Full Text] [Related]
19. [Hypotensive effect of encapsulated genetically engineered fibroblasts expressing mutant atrial natriuretic peptide in hypertensive rats]. Li T; Liang H; Lu G; Shi R; Lu S Zhonghua Yi Xue Za Zhi; 2002 Aug; 82(16):1086-9. PubMed ID: 12425814 [TBL] [Abstract][Full Text] [Related]
20. [Experimental genetic modifications in the renin-angiotensin and kallikrein-kinin systems: significance for understanding cardiovascular regulation and study of genetic determinism of human diseases]. Meneton P; Alhenc-Gelas F Nephrologie; 1998; 19(7):385-9. PubMed ID: 9857372 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]